Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,721 | 4,252 | 6,089 | 26 | 1,100 |
| Receivables | 4,049 | N/A | N/A | N/A | N/A |
| Inventories | 22,639 | 22,287 | 17,209 | 15,339 | 14,381 |
| TOTAL | $37,945 | $27,935 | $24,611 | $18,375 | $18,327 |
| Non-Current Assets | |||||
| Investments And Advances | 38 | 38 | 38 | 38 | 38 |
| Intangibles | 9,347 | 9,347 | 9,347 | 9,347 | 9,347 |
| Other Non-Current Assets | 93,062 | 93,619 | 93,681 | 93,722 | 92,991 |
| TOTAL | $102,447 | $103,004 | $103,066 | $103,107 | $102,376 |
| Total Assets | $140,392 | $130,938 | $127,677 | $121,481 | $120,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,021 | 13,694 | 10,094 | 9,368 | 7,364 |
| Accrued Expenses | 7,788 | 7,483 | 12,234 | 11,963 | 8,837 |
| Other current liabilities | 18,250 | 22,650 | 28,400 | 28,400 | 28,400 |
| TOTAL | $38,207 | $44,915 | $51,843 | $49,877 | $44,806 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,855 | 1,509 | 1,181 | 1,382 | 513 |
| TOTAL | $8,717 | $8,496 | $8,274 | $8,029 | $6,978 |
| Total Liabilities | $46,924 | $53,410 | $60,116 | $57,906 | $51,784 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,376 | 20,763 | 17,012 | 10,290 | 8,593 |
| Common Shares | 22 | 18 | 15 | 9 | 8 |
| Retained earnings | -247,025 | -238,804 | -230,845 | -222,055 | -211,139 |
| Other shareholders' equity | 13,510 | 9,977 | 2,502 | 2,916 | 3,512 |
| TOTAL | $93,468 | $77,528 | $67,561 | $63,576 | $68,920 |
| Total Liabilities And Equity | $140,392 | $130,938 | $127,677 | $121,481 | $120,704 |